Mersana Therapeutics, Inc. develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for ovarian cancer and NSCLC adenocarcinoma.
Market Cap | 418.052 Million | Shares Outstanding | 99.774 Million | Avg 30-day Volume | 1.559 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.61 |
Price to Revenue | 10209.6163 | Debt to Equity | 0.2023 | EBITDA | -168.003 Million |
Price to Book Value | 3.6061 | Operating Margin | -392693.0233 | Enterprise Value | 285.693 Million |
Current Ratio | 3.975 | EPS Growth | -0.685 | Quick Ratio | 3.744 |
1 Yr BETA | 1.4103 | 52-week High/Low | 8.34 / 2.68 | Profit Margin | -395488.3721 |
Operating Cash Flow Growth | -87.4103 | Altman Z-Score | -1.818 | Free Cash Flow to Firm | -108.651 Million |
Earnings Report | 2023-05-08 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
PROTOPAPAS ANNA PRESIDENT & CEO |
|
371,611 | 2023-01-13 | 1 |
CARVAJAL ALEJANDRA SVP, CHIEF LEGAL OFFICER |
|
227,405 | 2023-01-13 | 2 |
LOWINGER TIMOTHY B SVP, CHIEF SCI.&TECH. OFF. |
|
781,470 | 2023-01-13 | 2 |
DESCHUYTNER BRIAN SVP, CHIEF FINANCIAL OFFICER |
|
353,605 | 2023-01-13 | 1 |
MANDELIA ASHISH VP, CONTROLLER |
|
125,083 | 2023-01-13 | 1 |
YANG ARVIN SVP, CHIEF MEDICAL OFFICER |
|
350,933 | 2023-01-13 | 2 |
MISRA TUSHAR SVP, CMO |
|
172,525 | 2023-01-13 | 2 |
|
45,000 | 2022-06-09 | 1 | |
|
45,000 | 2022-06-09 | 1 | |
|
45,000 | 2022-06-09 | 1 | |
|
45,000 | 2022-06-09 | 1 | |
|
45,000 | 2022-06-09 | 1 | |
|
45,000 | 2022-06-09 | 7 | |
|
45,000 | 2022-06-09 | 1 | |
KAUFMAN MICHAEL J. CHIEF MANUFACTURING OFFICER |
|
77,332 | 2021-07-15 | 0 |
|
No longer subject to file | 2020-09-14 | 0 | |
|
No longer subject to file | 2020-09-14 | 0 | |
|
No longer subject to file | 2020-09-14 | 0 | |
|
No longer subject to file | 2020-09-14 | 0 | |
|
No longer subject to file | 2020-09-14 | 0 | |
|
No longer subject to file | 2020-09-14 | 0 | |
|
No longer subject to file | 2020-09-14 | 0 | |
JACK EVA M. CHIEF BUS. OFFICER, TRES, SEC. |
|
0 | 2020-09-14 | 0 |
HUEBNER DIRK CHIEF MEDICAL OFFICER |
|
0 | 2020-01-15 | 0 |
|
11,959,520 | 2019-08-28 | 0 | |
|
11,890,138 | 2019-03-05 | 0 | |
FOSTER WAYNE VICE PRESIDENT OF FINANCE |
|
0 | 2019-01-23 | 0 |
SPELLMAN DAVID A CHIEF FINANCIAL OFFICER |
|
0 | 2019-01-23 | 0 |
BERGSTROM DONALD A CHIEF MEDICAL OFFICER |
|
0 | 2018-02-02 | 0 |
|
0 | 2018-01-02 | 0 | |
|
No longer subject to file | 2017-07-03 | 0 | |
|
8,140,138 | 2017-07-03 | 0 | |
|
8,140,138 | 2017-07-03 | 0 | |
|
8,140,138 | 2017-07-03 | 0 | |
|
8,140,138 | 2017-07-03 | 0 | |
|
0 | 2017-06-27 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
MERSANA THERAPEUTICS INC MRSN | 2023-03-24 15:45:03 UTC | 4.4119 | 0.4081 | 900000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-24 15:15:03 UTC | 4.4119 | 0.4081 | 900000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-24 14:45:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-24 14:15:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-24 13:45:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-24 13:15:04 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-24 12:45:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 22:15:04 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 21:45:04 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 21:15:04 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 20:45:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 20:15:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 19:45:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 19:15:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 18:45:04 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 18:15:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 17:45:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 17:15:03 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 16:45:04 UTC | 4.1619 | 0.4081 | 950000 |
MERSANA THERAPEUTICS INC MRSN | 2023-03-23 16:15:03 UTC | 4.1619 | 0.4081 | 950000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|